 | • レポートコード：QYR9ST10368 • 出版社/出版日：QYResearch / 2019年9月5日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、拡張型心筋症治療薬の世界市場について調査・分析し、拡張型心筋症治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（アルドステロン拮抗薬、アンジオテンシン変換酵素（ACE）阻害薬、アンジオテンシンII受容体遮断薬（ARB）、ベータ遮断薬）、用途別（病院、学術機関）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の拡張型心筋症治療薬市場動向 ・主要企業別マーケットシェア ・拡張型心筋症治療薬の種類別市場規模2014-2019 （アルドステロン拮抗薬、アンジオテンシン変換酵素（ACE）阻害薬、アンジオテンシンII受容体遮断薬（ARB）、ベータ遮断薬） ・拡張型心筋症治療薬の用途別市場規模2014-2019 （病院、学術機関） ・拡張型心筋症治療薬の北米市場：主要企業・種類別/用途別市場規模 ・拡張型心筋症治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・拡張型心筋症治療薬の中国市場：主要企業・種類別/用途別市場規模 ・拡張型心筋症治療薬の日本国内市場：主要企業・種類別/用途別市場規模 ・拡張型心筋症治療薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・拡張型心筋症治療薬のインド市場：主要企業・種類別/用途別市場規模 ・拡張型心筋症治療薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Array BioPharma, Inc.、AstraZeneca plc.、Celladon Corporation、GlaxoSmithKline plc、Janssen Pharmaceuticals, Inc. (J&J)、Merck & Co., Inc.、Novartis International AG、Pfizer, Inc.、Sanofi S.A.、Teva Pharmaceutical Industries Ltd.、Vericel Corporation） ・拡張型心筋症治療薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Dilated cardiomyopathy (DCM) is characterized by LV (left ventricular) or biventricular systolic dysfunction and dilation, not explained by abnormal loading conditions or coronary artery disease.In 2018, the global Dilated Cardiomyopathy Therapeutic market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Dilated Cardiomyopathy Therapeutic status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Dilated Cardiomyopathy Therapeutic development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Array BioPharma, Inc.
AstraZeneca plc.
Celladon Corporation
GlaxoSmithKline plc
Janssen Pharmaceuticals, Inc. (J&J)
Merck & Co., Inc.
Novartis International AG
Pfizer, Inc.
Sanofi S.A.
Teva Pharmaceutical Industries Ltd.
Vericel Corporation
Market segment by Type, the product can be split into
Aldosterone antagonists
Angiotensin-converting enzyme (ACE) inhibitors
Angiotensin II receptor blockers (ARBs)
Beta-blockers
Market segment by Application, split into
Hospitals
Academic Institutions
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Dilated Cardiomyopathy Therapeutic status, future forecast, growth opportunity, key market and key players.
To present the Dilated Cardiomyopathy Therapeutic development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Dilated Cardiomyopathy Therapeutic are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Dilated Cardiomyopathy Therapeutic Market Size Growth Rate by Type (2014-2025)
1.4.2 Aldosterone antagonists
1.4.3 Angiotensin-converting enzyme (ACE) inhibitors
1.4.4 Angiotensin II receptor blockers (ARBs)
1.4.5 Beta-blockers
1.5 Market by Application
1.5.1 Global Dilated Cardiomyopathy Therapeutic Market Share by Application (2019-2025)
1.5.2 Hospitals
1.5.3 Academic Institutions
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Dilated Cardiomyopathy Therapeutic Market Size
2.2 Dilated Cardiomyopathy Therapeutic Growth Trends by Regions
2.2.1 Dilated Cardiomyopathy Therapeutic Market Size by Regions (2019-2025)
2.2.2 Dilated Cardiomyopathy Therapeutic Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Dilated Cardiomyopathy Therapeutic Market Size by by Players
3.1.1 Global Dilated Cardiomyopathy Therapeutic Revenue by by Players (2014-2019)
3.1.2 Global Dilated Cardiomyopathy Therapeutic Revenue Market Share by by Players (2014-2019)
3.1.3 Global Dilated Cardiomyopathy Therapeutic Market Concentration Ratio (CR5 and HHI)
3.2 Dilated Cardiomyopathy Therapeutic Key Players Head office and Area Served
3.3 Key Players Dilated Cardiomyopathy Therapeutic Product/Solution/Service
3.4 Date of Enter into Dilated Cardiomyopathy Therapeutic Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Dilated Cardiomyopathy Therapeutic Market Size by Type (2014-2019)
4.2 Global Dilated Cardiomyopathy Therapeutic Market Size by Application (2014-2019)
5 North America
5.1 North America Dilated Cardiomyopathy Therapeutic Market Size (2014-2019)
5.2 Dilated Cardiomyopathy Therapeutic Key Players in North America
5.3 North America Dilated Cardiomyopathy Therapeutic Market Size by Type
5.4 North America Dilated Cardiomyopathy Therapeutic Market Size by Application
6 Europe
6.1 Europe Dilated Cardiomyopathy Therapeutic Market Size (2014-2019)
6.2 Dilated Cardiomyopathy Therapeutic Key Players in Europe
6.3 Europe Dilated Cardiomyopathy Therapeutic Market Size by Type
6.4 Europe Dilated Cardiomyopathy Therapeutic Market Size by Application
7 China
7.1 China Dilated Cardiomyopathy Therapeutic Market Size (2014-2019)
7.2 Dilated Cardiomyopathy Therapeutic Key Players in China
7.3 China Dilated Cardiomyopathy Therapeutic Market Size by Type
7.4 China Dilated Cardiomyopathy Therapeutic Market Size by Application
8 Japan
8.1 Japan Dilated Cardiomyopathy Therapeutic Market Size (2014-2019)
8.2 Dilated Cardiomyopathy Therapeutic Key Players in Japan
8.3 Japan Dilated Cardiomyopathy Therapeutic Market Size by Type
8.4 Japan Dilated Cardiomyopathy Therapeutic Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Dilated Cardiomyopathy Therapeutic Market Size (2014-2019)
9.2 Dilated Cardiomyopathy Therapeutic Key Players in Southeast Asia
9.3 Southeast Asia Dilated Cardiomyopathy Therapeutic Market Size by Type
9.4 Southeast Asia Dilated Cardiomyopathy Therapeutic Market Size by Application
10 India
10.1 India Dilated Cardiomyopathy Therapeutic Market Size (2014-2019)
10.2 Dilated Cardiomyopathy Therapeutic Key Players in India
10.3 India Dilated Cardiomyopathy Therapeutic Market Size by Type
10.4 India Dilated Cardiomyopathy Therapeutic Market Size by Application
11 Central & South America
11.1 Central & South America Dilated Cardiomyopathy Therapeutic Market Size (2014-2019)
11.2 Dilated Cardiomyopathy Therapeutic Key Players in Central & South America
11.3 Central & South America Dilated Cardiomyopathy Therapeutic Market Size by Type
11.4 Central & South America Dilated Cardiomyopathy Therapeutic Market Size by Application
12 International Players Profiles
12.1 Array BioPharma, Inc.
12.1.1 Array BioPharma, Inc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Dilated Cardiomyopathy Therapeutic Introduction
12.1.4 Array BioPharma, Inc. Revenue in Dilated Cardiomyopathy Therapeutic Business (2014-2019))
12.1.5 Array BioPharma, Inc. Recent Development
12.2 AstraZeneca plc.
12.2.1 AstraZeneca plc. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Dilated Cardiomyopathy Therapeutic Introduction
12.2.4 AstraZeneca plc. Revenue in Dilated Cardiomyopathy Therapeutic Business (2014-2019)
12.2.5 AstraZeneca plc. Recent Development
12.3 Celladon Corporation
12.3.1 Celladon Corporation Company Details
12.3.2 Company Description and Business Overview
12.3.3 Dilated Cardiomyopathy Therapeutic Introduction
12.3.4 Celladon Corporation Revenue in Dilated Cardiomyopathy Therapeutic Business (2014-2019)
12.3.5 Celladon Corporation Recent Development
12.4 GlaxoSmithKline plc
12.4.1 GlaxoSmithKline plc Company Details
12.4.2 Company Description and Business Overview
12.4.3 Dilated Cardiomyopathy Therapeutic Introduction
12.4.4 GlaxoSmithKline plc Revenue in Dilated Cardiomyopathy Therapeutic Business (2014-2019)
12.4.5 GlaxoSmithKline plc Recent Development
12.5 Janssen Pharmaceuticals, Inc. (J&J)
12.5.1 Janssen Pharmaceuticals, Inc. (J&J) Company Details
12.5.2 Company Description and Business Overview
12.5.3 Dilated Cardiomyopathy Therapeutic Introduction
12.5.4 Janssen Pharmaceuticals, Inc. (J&J) Revenue in Dilated Cardiomyopathy Therapeutic Business (2014-2019)
12.5.5 Janssen Pharmaceuticals, Inc. (J&J) Recent Development
12.6 Merck & Co., Inc.
12.6.1 Merck & Co., Inc. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Dilated Cardiomyopathy Therapeutic Introduction
12.6.4 Merck & Co., Inc. Revenue in Dilated Cardiomyopathy Therapeutic Business (2014-2019)
12.6.5 Merck & Co., Inc. Recent Development
12.7 Novartis International AG
12.7.1 Novartis International AG Company Details
12.7.2 Company Description and Business Overview
12.7.3 Dilated Cardiomyopathy Therapeutic Introduction
12.7.4 Novartis International AG Revenue in Dilated Cardiomyopathy Therapeutic Business (2014-2019)
12.7.5 Novartis International AG Recent Development
12.8 Pfizer, Inc.
12.8.1 Pfizer, Inc. Company Details
12.8.2 Company Description and Business Overview
12.8.3 Dilated Cardiomyopathy Therapeutic Introduction
12.8.4 Pfizer, Inc. Revenue in Dilated Cardiomyopathy Therapeutic Business (2014-2019)
12.8.5 Pfizer, Inc. Recent Development
12.9 Sanofi S.A.
12.9.1 Sanofi S.A. Company Details
12.9.2 Company Description and Business Overview
12.9.3 Dilated Cardiomyopathy Therapeutic Introduction
12.9.4 Sanofi S.A. Revenue in Dilated Cardiomyopathy Therapeutic Business (2014-2019)
12.9.5 Sanofi S.A. Recent Development
12.10 Teva Pharmaceutical Industries Ltd.
12.10.1 Teva Pharmaceutical Industries Ltd. Company Details
12.10.2 Company Description and Business Overview
12.10.3 Dilated Cardiomyopathy Therapeutic Introduction
12.10.4 Teva Pharmaceutical Industries Ltd. Revenue in Dilated Cardiomyopathy Therapeutic Business (2014-2019)
12.10.5 Teva Pharmaceutical Industries Ltd. Recent Development
12.11 Vericel Corporation
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Dilated Cardiomyopathy Therapeutic Key Market Segments
Table Key Players Dilated Cardiomyopathy Therapeutic Covered
Table Global Dilated Cardiomyopathy Therapeutic Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Aldosterone antagonists Figures
Table Key Players of Aldosterone antagonists
Figuer Angiotensin-converting enzyme (ACE) inhibitors Figures
Table Key Players of Angiotensin-converting enzyme (ACE) inhibitors
Figuer Angiotensin II receptor blockers (ARBs) Figures
Table Key Players of Angiotensin II receptor blockers (ARBs)
Figuer Beta-blockers Figures
Table Key Players of Beta-blockers
Table Global Dilated Cardiomyopathy Therapeutic Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Dilated Cardiomyopathy Therapeutic Market Share by Application in 2018 & 2025
Figure Hospitals Case Studies
Figure Academic Institutions Case Studies
Figure Dilated Cardiomyopathy Therapeutic Report Years Considered
Figure Global Dilated Cardiomyopathy Therapeutic Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Dilated Cardiomyopathy Therapeutic Market Size by Regions 2019-2025 (Million US$)
Table Global Dilated Cardiomyopathy Therapeutic Market Size by Regions 2019-2025 (Million US$)
Table Global Dilated Cardiomyopathy Therapeutic Market Share by Regions 2014-2019
Figure Global Dilated Cardiomyopathy Therapeutic Market Share by Regions 2014-2019
Figure Global Dilated Cardiomyopathy Therapeutic Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Dilated Cardiomyopathy Therapeutic Revenue by by Players (2014-2019) (Million US$)
Table Global Dilated Cardiomyopathy Therapeutic Market Share by by Players (2014-2019)
Figure Global Dilated Cardiomyopathy Therapeutic Market Share by by Players in 2018
Table Global Dilated Cardiomyopathy Therapeutic by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Dilated Cardiomyopathy Therapeutic Product/Solution/Service
Table Date of Enter into Dilated Cardiomyopathy Therapeutic Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Dilated Cardiomyopathy Therapeutic Market Size by Type (2014-2019) (Million US$)
Table Global Dilated Cardiomyopathy Therapeutic Market Size Share by Type (2014-2019)
Figure Global Dilated Cardiomyopathy Therapeutic Market Size Market Share by Type (2014-2019)
Table Global Dilated Cardiomyopathy Therapeutic Market Size by Application (2014-2019) (Million US$)
Table Global Dilated Cardiomyopathy Therapeutic Market Size Share by Application (2014-2019)
Figure Global Dilated Cardiomyopathy Therapeutic Market Size Market Share by Application (2014-2019)
Figure Global Dilated Cardiomyopathy Therapeutic Revenue Market Share by Application in 2018
Figure North America Dilated Cardiomyopathy Therapeutic Market Size 2014-2019 (Million US$)
Table North America Key Players Dilated Cardiomyopathy Therapeutic Revenue (2018-2019) (Million US$)
Table North America Key Players Dilated Cardiomyopathy Therapeutic Market Share (2018-2019)
Table North America Dilated Cardiomyopathy Therapeutic Market Size by Type 2014-2019 (Million US$)
Table North America Dilated Cardiomyopathy Therapeutic Market Share by Type 2014-2019
Table North America Dilated Cardiomyopathy Therapeutic Market Size by Application 2014-2019 (Million US$)
Table North America Dilated Cardiomyopathy Therapeutic Market Share by Application 2014-2019
Figure Europe Dilated Cardiomyopathy Therapeutic Market Size 2014-2019 (Million US$)
Table Europe Key Players Dilated Cardiomyopathy Therapeutic Revenue (2018-2019) (Million US$)
Table Europe Key Players Dilated Cardiomyopathy Therapeutic Market Share (2018-2019)
Table Europe Dilated Cardiomyopathy Therapeutic Market Size by Type 2014-2019 (Million US$)
Table Europe Dilated Cardiomyopathy Therapeutic Market Share by Type 2014-2019
Table Europe Dilated Cardiomyopathy Therapeutic Market Size by Application 2014-2019 (Million US$)
Table Europe Dilated Cardiomyopathy Therapeutic Market Share by Application 2014-2019
Figure China Dilated Cardiomyopathy Therapeutic Market Size 2014-2019 (Million US$)
Table China Key Players Dilated Cardiomyopathy Therapeutic Revenue (2018-2019) (Million US$)
Table China Key Players Dilated Cardiomyopathy Therapeutic Market Share (2018-2019)
Table China Dilated Cardiomyopathy Therapeutic Market Size by Type 2014-2019 (Million US$)
Table China Dilated Cardiomyopathy Therapeutic Market Share by Type 2014-2019
Table China Dilated Cardiomyopathy Therapeutic Market Size by Application 2014-2019 (Million US$)
Table China Dilated Cardiomyopathy Therapeutic Market Share by Application 2014-2019
Figure Japan Dilated Cardiomyopathy Therapeutic Market Size 2014-2019 (Million US$)
Table Japan Key Players Dilated Cardiomyopathy Therapeutic Revenue (2018-2019) (Million US$)
Table Japan Key Players Dilated Cardiomyopathy Therapeutic Market Share (2018-2019)
Table Japan Dilated Cardiomyopathy Therapeutic Market Size by Type 2014-2019 (Million US$)
Table Japan Dilated Cardiomyopathy Therapeutic Market Share by Type 2014-2019
Table Japan Dilated Cardiomyopathy Therapeutic Market Size by Application 2014-2019 (Million US$)
Table Japan Dilated Cardiomyopathy Therapeutic Market Share by Application 2014-2019
Figure Southeast Asia Dilated Cardiomyopathy Therapeutic Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Dilated Cardiomyopathy Therapeutic Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Dilated Cardiomyopathy Therapeutic Market Share (2018-2019)
Table Southeast Asia Dilated Cardiomyopathy Therapeutic Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Dilated Cardiomyopathy Therapeutic Market Share by Type 2014-2019
Table Southeast Asia Dilated Cardiomyopathy Therapeutic Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Dilated Cardiomyopathy Therapeutic Market Share by Application 2014-2019
Figure India Dilated Cardiomyopathy Therapeutic Market Size 2014-2019 (Million US$)
Table India Key Players Dilated Cardiomyopathy Therapeutic Revenue (2018-2019) (Million US$)
Table India Key Players Dilated Cardiomyopathy Therapeutic Market Share (2018-2019)
Table India Dilated Cardiomyopathy Therapeutic Market Size by Type 2014-2019 (Million US$)
Table India Dilated Cardiomyopathy Therapeutic Market Share by Type 2014-2019
Table India Dilated Cardiomyopathy Therapeutic Market Size by Application 2014-2019 (Million US$)
Table India Dilated Cardiomyopathy Therapeutic Market Share by Application 2014-2019
Figure Central & South America Dilated Cardiomyopathy Therapeutic Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Dilated Cardiomyopathy Therapeutic Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Dilated Cardiomyopathy Therapeutic Market Share (2018-2019)
Table Central & South America Dilated Cardiomyopathy Therapeutic Market Size by Type 2014-2019 (Million US$)
Table Central & South America Dilated Cardiomyopathy Therapeutic Market Share by Type 2014-2019
Table Central & South America Dilated Cardiomyopathy Therapeutic Market Size by Application 2014-2019 (Million US$)
Table Central & South America Dilated Cardiomyopathy Therapeutic Market Share by Application 2014-2019
Table Array BioPharma, Inc. Company Details
Table Array BioPharma, Inc. Revenue in Dilated Cardiomyopathy Therapeutic Business 2014-2019 (Million US$)
Figure Array BioPharma, Inc. Revenue Growth Rate in Dilated Cardiomyopathy Therapeutic Business (2014-2019)
Table Array BioPharma, Inc. Recent Development
Table AstraZeneca plc. Company Details
Table AstraZeneca plc. Revenue in Dilated Cardiomyopathy Therapeutic Business 2014-2019 (Million US$)
Figure AstraZeneca plc. Revenue Growth Rate in Dilated Cardiomyopathy Therapeutic Business (2014-2019)
Table AstraZeneca plc. Recent Development
Table Celladon Corporation Company Details
Table Celladon Corporation Revenue in Dilated Cardiomyopathy Therapeutic Business 2014-2019 (Million US$)
Figure Celladon Corporation Revenue Growth Rate in Dilated Cardiomyopathy Therapeutic Business (2014-2019)
Table Celladon Corporation Recent Development
Table GlaxoSmithKline plc Company Details
Table GlaxoSmithKline plc Revenue in Dilated Cardiomyopathy Therapeutic Business 2014-2019 (Million US$)
Figure GlaxoSmithKline plc Revenue Growth Rate in Dilated Cardiomyopathy Therapeutic Business (2014-2019)
Table GlaxoSmithKline plc Recent Development
Table Janssen Pharmaceuticals, Inc. (J&J) Company Details
Table Janssen Pharmaceuticals, Inc. (J&J) Revenue in Dilated Cardiomyopathy Therapeutic Business 2014-2019 (Million US$)
Figure Janssen Pharmaceuticals, Inc. (J&J) Revenue Growth Rate in Dilated Cardiomyopathy Therapeutic Business (2014-2019)
Table Janssen Pharmaceuticals, Inc. (J&J) Recent Development
Table Merck & Co., Inc. Company Details
Table Merck & Co., Inc. Revenue in Dilated Cardiomyopathy Therapeutic Business 2014-2019 (Million US$)
Figure Merck & Co., Inc. Revenue Growth Rate in Dilated Cardiomyopathy Therapeutic Business (2014-2019)
Table Merck & Co., Inc. Recent Development
Table Novartis International AG Company Details
Table Novartis International AG Revenue in Dilated Cardiomyopathy Therapeutic Business 2014-2019 (Million US$)
Figure Novartis International AG Revenue Growth Rate in Dilated Cardiomyopathy Therapeutic Business (2014-2019)
Table Novartis International AG Recent Development
Table Pfizer, Inc. Company Details
Table Pfizer, Inc. Revenue in Dilated Cardiomyopathy Therapeutic Business 2014-2019 (Million US$)
Figure Pfizer, Inc. Revenue Growth Rate in Dilated Cardiomyopathy Therapeutic Business (2014-2019)
Table Pfizer, Inc. Recent Development
Table Sanofi S.A. Company Details
Table Sanofi S.A. Revenue in Dilated Cardiomyopathy Therapeutic Business 2014-2019 (Million US$)
Figure Sanofi S.A. Revenue Growth Rate in Dilated Cardiomyopathy Therapeutic Business (2014-2019)
Table Sanofi S.A. Recent Development
Table Teva Pharmaceutical Industries Ltd. Company Details
Table Teva Pharmaceutical Industries Ltd. Revenue in Dilated Cardiomyopathy Therapeutic Business 2014-2019 (Million US$)
Figure Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Dilated Cardiomyopathy Therapeutic Business (2014-2019)
Table Teva Pharmaceutical Industries Ltd. Recent Development
Table Vericel Corporation Company Details
Table Global Dilated Cardiomyopathy Therapeutic Market Size by Regions (Million US$) 2019-2025
Figure Global Dilated Cardiomyopathy Therapeutic Market Size Share by Regions (2019-2025)
Figure Global Dilated Cardiomyopathy Therapeutic Market Size Share by Regions in 2025
Figure North America Dilated Cardiomyopathy Therapeutic Market Size Forecast (2019-2025)(Million USD)
Figure Europe Dilated Cardiomyopathy Therapeutic Market Size Forecast (2019-2025)(Million USD)
Figure China Dilated Cardiomyopathy Therapeutic Market Size Forecast (2019-2025)(Million USD)
Figure Japan Dilated Cardiomyopathy Therapeutic Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Dilated Cardiomyopathy Therapeutic Market Size Forecast (2019-2025)(Million USD)
Figure India Dilated Cardiomyopathy Therapeutic Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Dilated Cardiomyopathy Therapeutic Market Size Forecast (2019-2025)(Million USD)
Table Global Dilated Cardiomyopathy Therapeutic Market Size by Product (2019-2025) (Million US$)
Figure Global Dilated Cardiomyopathy Therapeutic Market Size by Product (2019-2025)
Figure Global Dilated Cardiomyopathy Therapeutic Market Size by Product in 2025
Table Global Dilated Cardiomyopathy Therapeutic Market Size by Application (2019-2025) (Million US$)
Figure Global Dilated Cardiomyopathy Therapeutic Market Size by Application (2019-2025)
Figure Global Dilated Cardiomyopathy Therapeutic Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
拡張型心筋症治療の世界市場：市場規模・現状・予測 Dilated Cardiomyopathy (DCM) is a condition in which heart's left ventricle, is enlarged and weakened and the ability to pump blood is decreased.The growth in DCM treatment market is due to prominent rise in number of heart failure patients worldwide over the years, R&D activities and increased awar…- 肥大型心筋症治療薬の世界市場：市場規模・現状・予測 HCM is the enlargement of the heart muscle (myocardium), which disrupts the functions of the heart. HCM is mostly caused due to gene mutation and is a significant cause of sudden cardiac death in any age group. Hypertrophy is defined as an enlargement of a tissue or organ, and cardiomyopathy refers …
- 心筋症の世界市場：市場規模・現状・予測 Cardiomyopathy refers to diseases of the heart muscleThe major factors that contributes in the growth of the market are advancement in understanding and managing cardiomyopathy and rise in incidences of congestive heart failure, coronary heart disease, and heart attack. Further, increasing trend of …
- 降圧薬の世界市場：インサイト・予測 Increase in blood pressure is measured in terms of systolic and diastolic blood pressure exerted by blood on the wall of artery and hence it is also termed as arterial hypertension. Reduction in blood pressure minimizes the risk of heart failure, ischaemic heart diseases, dementia and mortality due …
- 腎線維症治療の世界市場：市場規模・現状・予測 Kidney or renal fibrosis is the body process from which the kidney’s excess fibrous connective tissue or organs takes its formation repetitively.Increasing prevalence of chronic diseases such as kidney disorders is expected to trigger the growth of this market over the forecast period. Changing life…